Affy to Relocate Array Manufacturing to Singapore in Cost-Cutting Plan | GenomeWeb
NEW YORK (GenomeWeb News) – Affymetrix plans to move the “majority” of its probe array manufacturing from its West Sacramento, Calif., facility to its Singapore facility by the end of 2008, the company said in a filing with the US Securities and Exchange Commission on Friday.
 
In the filing, the company said that the restructuring was approved on Feb. 28 as part of an ongoing effort to reduce costs.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.